Who
Catherine M. Szyman
Chief Executive Officer
Company insider
Files Form 4 as: Chief Executive Officer, Masimo; Director, Inari Medical; CVP, Critical Care, Edwards Lifesciences; Director, Outset Medical; SrVP & Pres Diabetes, Medtronic.
In numbers
- Trades disclosed
- 319
- Buys
- 2
- Sells
- 61
- Bought
- $1.6M
- Sold
- $49.9M
- Companies
- 5
- Companies where not an officer
- 2
- First trade
- 10 Jul 2008
- Last trade
- 10 Jun 2026
- Last filed
- 12 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 10 Jun 2026filed 12 Jun 2026 | MasimoMedical Devices | SEC FORM 4 Code D | $1.4M7,605 at $180.00 | filing |
| 10 Jun 2026filed 12 Jun 2026 | Masimooption or derivative · Medical Devices | SEC FORM 4 Code D | —22,283 | filing |
| 10 Jun 2026filed 12 Jun 2026 | Masimooption or derivative · Medical Devices | SEC FORM 4 Code D | —6,306 | filing |
| 10 Jun 2026filed 12 Jun 2026 | Masimooption or derivative | SEC FORM 4 Code D | —22,283 | filing |
| 10 Jun 2026filed 12 Jun 2026 | Masimooption or derivative | SEC FORM 4 Code D | —6,306 | filing |
| 10 Jun 2026filed 12 Jun 2026 | Masimooption or derivative | SEC FORM 4 Code D | —39,904 | filing |
| 10 Jun 2026filed 12 Jun 2026 | Masimooption or derivative | SEC FORM 4 Code D | $251K18,617 at $13.48 | filing |
| 10 Jun 2026filed 12 Jun 2026 | Masimooption or derivative | SEC FORM 4 Code D | $8.9M49,243 at $180.00 | filing |
| 10 Jun 2026filed 12 Jun 2026 | Masimooption or derivative · Medical Devices | SEC FORM 4 Code D | —39,904 | filing |
| 10 Jun 2026filed 12 Jun 2026 | Masimooption or derivative · Medical Devices | SEC FORM 4 Code D | $251K18,617 at $13.48 | filing |
| 10 Jun 2026filed 12 Jun 2026 | Masimooption or derivative · Medical Devices | SEC FORM 4 Code D | $8.9M49,243 at $180.00 | filing |
| 10 Jun 2026filed 12 Jun 2026 | Masimo | SEC FORM 4 Code D | $1.4M7,605 at $180.00 | filing |
| 11 Mar 2026filed 16 Mar 2026 | MasimoMedical Devices | SEC FORM 4 Code M | —2,101 at $0.00 | filing |
| 11 Mar 2026filed 16 Mar 2026 | MasimoMedical Devices | SEC FORM 4 Code F | $188K1,069 at $175.47 | filing |
| 11 Mar 2026filed 16 Mar 2026 | Masimooption or derivative · Medical Devices | SEC FORM 4 Code M | —2,101 at $0.00 | filing |
| 11 Mar 2026filed 16 Mar 2026 | Masimooption or derivative | SEC FORM 4 Code M | —2,101 at $0.00 | filing |
| 11 Mar 2026filed 16 Mar 2026 | Masimo | SEC FORM 4 Code M | —2,101 at $0.00 | filing |
| 11 Mar 2026filed 16 Mar 2026 | Masimo | SEC FORM 4 Code F | $188K1,069 at $175.47 | filing |
| 6 Mar 2026filed 10 Mar 2026 | Masimooption or derivative · Medical Devices | SEC FORM 4 Code A | —39,904 at $0.00 | filing |
| 6 Mar 2026filed 10 Mar 2026 | Masimooption or derivative | SEC FORM 4 Code A | —39,904 at $0.00 | filing |
News
Edwards Lifesciences (NYSE:EW) Upgraded to "Buy" at Wall Street ZenEW · dailypolitical.com · 18 Oct 2026Bangkok Post - Edwards Lifesciences Thailand Marks 25 Years in Thailand WITH Access to Heart Valve CareEW · bangkokpost.com · 14 Oct 2026Edwards Lifesciences (NYSE:EW) Shares Break Above 200-Day Moving Average – What's Next?EW · dailypolitical.com · 7 Oct 2026
0 headlines in the last 90 days name Catherine M. Szyman; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.